Effect of flecainide derivatives on sarcoplasmic reticulum calcium release suggests a lack of direct action on the cardiac ryanodine receptor
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of flecainide derivatives on sarcoplasmic reticulum calcium release suggests a lack of direct action on the cardiac ryanodine receptor
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 173, Issue 15, Pages 2446-2459
Publisher
Wiley
Online
2016-05-30
DOI
10.1111/bph.13521
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade
- (2016) Gareth J. Padfield et al. HEART RHYTHM
- Flecainide monotherapy for catecholaminergic polymorphic ventricular tachycardia: Perspectives and limitations
- (2016) Carlo Napolitano HEART RHYTHM
- The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels
- (2015) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2015/16: Transporters
- (2015) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2015/16: Voltage-gated ion channels
- (2015) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Experimental design and analysis and their reporting: new guidance for publication in BJP
- (2015) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP
- (2015) John C McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Mechanism of Flecainide Action in CPVT Does Not Involve a Direct Effect on RyR2
- (2015) M. L. Bannister et al. CIRCULATION RESEARCH
- Molecular basis of hERG potassium channel blockade by the class Ic antiarrhythmic flecainide
- (2015) Dario Melgari et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
- (2015) Christopher Southan et al. NUCLEIC ACIDS RESEARCH
- Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging
- (2015) Gaetano Santulli et al. Current Molecular Pharmacology
- Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyocytes
- (2015) Eleonora Savio-Galimberti et al. PLoS One
- Triple mode of action of flecainide in catecholaminergic polymorphic ventricular tachycardia
- (2013) D. S. Steele et al. CARDIOVASCULAR RESEARCH
- Triple mode of action of flecainide in catecholaminergic polymorphic ventricular tachycardia: reply
- (2013) M. B. Sikkel et al. CARDIOVASCULAR RESEARCH
- Flecainide reduces Ca2+ spark and wave frequency via inhibition of the sarcolemmal sodium current
- (2013) Markus B. Sikkel et al. CARDIOVASCULAR RESEARCH
- Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia
- (2013) Hiroshi Watanabe et al. HEART RHYTHM
- Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia
- (2012) Christian van der Werf et al. Circulation-Arrhythmia and Electrophysiology
- Ryanodine receptor inhibition potentiates the activity of Na channel blockers against spontaneous calcium elevations and delayed afterdepolarizations in Langendorff-perfused rabbit ventricles
- (2012) Young Soo Lee et al. HEART RHYTHM
- The contribution of hydrophobic residues in the pore-forming region of the ryanodine receptor channel to block by large tetraalkylammonium cations andShakerB inactivation peptides
- (2012) Sammy A. Mason et al. JOURNAL OF GENERAL PHYSIOLOGY
- A mechanistic description of gating of the human cardiac ryanodine receptor in a regulated minimal environment
- (2012) Saptarshi Mukherjee et al. JOURNAL OF GENERAL PHYSIOLOGY
- Short Communication: Flecainide Exerts an Antiarrhythmic Effect in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia by Increasing the Threshold for Triggered Activity
- (2011) Nian Liu et al. CIRCULATION RESEARCH
- Inhibition of Cardiac Ca 2+ Release Channels (RyR2) Determines Efficacy of Class I Antiarrhythmic Drugs in Catecholaminergic Polymorphic Ventricular Tachycardia
- (2011) Hyun Seok Hwang et al. Circulation-Arrhythmia and Electrophysiology
- Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin
- (2011) Eleonora Savio Galimberti et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Flecainide Therapy Reduces Exercise-Induced Ventricular Arrhythmias in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
- (2011) Christian van der Werf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ryanodine receptor calcium channels and their partners as drug targets
- (2010) John J. Mackrill BIOCHEMICAL PHARMACOLOGY
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
- (2010) Carol Kilkenny et al. PLOS BIOLOGY
- Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass
- (2009) Fredrick A. Hilliard et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans
- (2009) Hiroshi Watanabe et al. NATURE MEDICINE
- Intracellular Calcium Release Channels Mediate Their Own Countercurrent: The Ryanodine Receptor Case Study
- (2008) Dirk Gillespie et al. BIOPHYSICAL JOURNAL
- Electrostatic Contributions of Aromatic Residues in the Local Anesthetic Receptor of Voltage-Gated Sodium Channels
- (2007) Christopher A. Ahern et al. CIRCULATION RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started